Regular screening from age 45 is recommended to help find colon cancer early. Get started the easy way.
Early Detection,
Made Simple
Early Detection,
Made Simple
Made Simple
A simple, private, FDA-Approved at-home alternative to colonoscopy for cancer screening*
A simple, private, FDA-Approved at-home alternative to colonoscopy for cancer screening*
*For people at average risk of colon cancer who are unwilling or unable to complete a colonoscopy. A follow-up colonoscopy is recommended if the screening test is positive.
OUR PROCESS
How It Works
How It Works
We keep it simple.
We keep it simple.
1. Take Our Survey and See If You Qualify
1. Take Our Survey and See If You Qualify
ColoSense is intended for patients 45 years of age or older that are due for a colon cancer screening and NOT at high risk of colon cancer.
2. Place Your Order Online
2. Place Your Order Online
If you qualify, you can easily order your ColoSense test through our secure patient portal. You’ll provide your insurance information so our agents can confirm your coverage, and enter your shipping address. Because ColoSense requires a healthcare professional’s order, we offer a simple $6 telehealth review (no office visit or co-pay required) and our healthcare professionals will review your information and place the order for you.
3. Receive Your ColoSense Kit
3. Receive Your ColoSense Kit
We'll send you everything you need to comfortably, easily, and privately provide a stool sample. No extra thought or materials required.
4. Send in Your Sample
4. Send in Your Sample
We'll provide a prepaid FedEx shipping label in the kit so you can take the sample to your nearest FedEx or FedEx drop location and be on your way.
5. Receive Your Result
5. Receive Your Result
You'll receive your result in approximately 2 weeks. A healthcare professional will be able to discuss your result and help with next steps if the test indicates you may need further testing.
Why choose ColoSense for colon cancer screening?
Why choose ColoSense for colon cancer screening?
ColoSense is simple, private, and clinically validated for accuracy. With FDA-approved RNA science and a collection process designed for comfort, ColoSense helps you screen confidently from your home with no prep, no dietary changes, and no time off work.
37% of people who are eligible for colon cancer screening have not completed any screening test¹.
FDA-approved and clinically validated to detect signs of colon cancer early.
No messy manipulation and handling of the stool sample required.
Frequently Asked Questions
Frequently Asked Questions
What is ColoSense? +
ColoSense is a simple stool test that screens for colon cancer cancer. It looks for RNA markers associated with colon cancer and for hidden signs of blood in a stool sample, offering a non-invasive screening option for people who are unwilling or unable to complete a colonoscopy.
Who should take this test? +
This test is for adults 45 and older who are at average risk for colon cancer and want a more convenient way to get screened. See if you qualify.
Is this test safe? +
Yes. ColoSense only requires a stool sample.
Do I have to handle and separate my stool? +
No, unlike other at-home stool-based tests, ColoSense has no probe component, so no messy manipulation or handling of the stool sample is required.
How much does it cost, and can I use insurance? +
Most insured patients pay $0 out of pocket for screening. The only requirement is that a healthcare professional must order your test for you. We offer a $6 telehealth review completed online by our healthcare professionals, no office visit required.
How does it compare to other screening options? +
ColoSense is the only test to use advanced RNA science. It's FDA-approved and clinically validated to detect signs of colon cancer early. ColoSense is simple, accurate, and private. There's no prep, no dietary changes, and no time off work required. Unlike other at-home, stool-based colon cancer screening tests, ColoSense does not require a probing/scraping step, so there is no need for messy and unpleasant handling of the stool sample.
What happens after I take the survey? +
You'll find out if you qualify! If you do, you will be taken to our secure patient portal to complete your order and pay your $6 telemedicine fee. No office visit required. See if you qualify.
How accurate is the test? +
ColoSense is FDA-approved and clinically validated to detect signs of colon cancer early. The ColoSense test showed 100% sensitivity for Stage I cancer (n = 12, average risk).4
Performance was assessed in a clinical study of 7,763 average risk patients. In this study, ColoSense demonstrated:
- 93% sensitivity for detection of colon cancer
- 88% specificity for no lesions on colonoscopy
- 45% sensitivity for detection of advanced adenomas
Additional information can be found on the FDA website: FDA Premarket Approval
Performance was assessed in a clinical study of 7,763 average risk patients. In this study, ColoSense demonstrated:
- 93% sensitivity for detection of colon cancer
- 88% specificity for no lesions on colonoscopy
- 45% sensitivity for detection of advanced adenomas
Additional information can be found on the FDA website: FDA Premarket Approval
REFERENCES
1. American Cancer Society. Colorectal Cancer Facts & Figures 2020-2022. Atlanta, American Cancer Society; 2020.
2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48.
3. American Cancer Society. Colorectal Cancer Facts & Figures 2023-2025. Atlanta: American Cancer Society; 2023.
4. Barnell EK, Wurtzler EM, La Rocca J, et al. Multitarget Stool RNA Test for Colorectal Cancer Screening. JAMA. 2023;330(18):1760–1768.
2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48.
3. American Cancer Society. Colorectal Cancer Facts & Figures 2023-2025. Atlanta: American Cancer Society; 2023.
4. Barnell EK, Wurtzler EM, La Rocca J, et al. Multitarget Stool RNA Test for Colorectal Cancer Screening. JAMA. 2023;330(18):1760–1768.
All trademarks, registered or otherwise, are the property of their respective owner(s).
© 2025 Geneoscopy, Inc. All rights reserved.
MKT-TD-0025v0
© 2025 Geneoscopy, Inc. All rights reserved.
MKT-TD-0025v0